Pharma

Divis Laboratories Ltd

DIVISLAB · NSE · INE361B01024
₹9,415.7-0.71%consolidatedstandalone
Thursday, 10 Sept 202612:31 pm
Sentiment88 · Extreme Greed
Extreme FearFearNeutralGreedExtreme Greed
Market Cap₹2,50,065 Cr
P/E83.9
P/B14.9
EPS₹112.22
Div Yield0.3%
ROE16.5%
ROCE22.0%
ROE16.5%
1Y Return+46.29%
Avg. Volume0.5M

Price Chart

9,4678,5227,5776,6325,6889.6L19.3LSept 2025Oct 2025Nov 2025Jan 2026Feb 2026Mar 2026May 2026Jul 2026Sept 2026

52-Week Range

₹5,636.5₹9,415.7₹9,615
52W Low52W High

About

Divis Laboratories Ltd is a Pharma company listed on NSE.

Pharma

Technicals

Free account

Technicals

Create a free account to view momentum, moving averages, and delivery signals.

Register free

Quant

Premium

Quant metrics

Upgrade to view volatility, drawdown, factor, and risk metrics.

Upgrade

Key Ratios

Market Cap₹2,50,065 Cr
Current Price₹9,415.7
52W High / Low₹9,615 / ₹5,636.5
Stock P/E83.9
Price to Book14.9
EPS (TTM)₹112.22
Dividend Yield0.3%
ROE16.5%
1Y Return+46.29%
Day Change-0.71%

Profit & Loss

ConsolidatedStandalone
Profit and loss statement
PeriodTTMFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15
Sales₹11,230 Cr₹10,560 Cr₹9,360 Cr
Expenses₹7,263 Cr₹7,118 Cr₹6,387 Cr
Operating Profit₹3,967 Cr₹3,442 Cr₹2,973 Cr
OPM %35.0%33.0%32.0%
Other Income₹378 Cr₹433 Cr₹348 Cr
Depreciation₹484 Cr₹463 Cr₹402 Cr
Interest₹26 Cr₹24 Cr₹3 Cr
Profit Before Tax₹3,835 Cr₹3,388 Cr₹2,916 Cr
Tax₹910 Cr₹820 Cr₹725 Cr
Net Profit₹2,925 Cr₹2,568 Cr₹2,191 Cr
EPS (₹)110.296.782.5
Dividend Payout %—31%36%
Financial history locked

Register free to see 10 more years.

Register free

Quarterly Results

Quarterly results
QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Sales₹3,080 Cr₹2,831 Cr₹2,604 Cr₹2,715 Cr
Expenses₹1,825 Cr₹1,897 Cr₹1,714 Cr₹1,827 Cr
Operating Profit₹1,255 Cr₹934 Cr₹890 Cr₹888 Cr
OPM %41.0%33.0%34.0%33.0%
Depreciation₹133 Cr₹120 Cr₹118 Cr₹113 Cr
Interest₹6 Cr₹6 Cr₹6 Cr₹8 Cr
Net Profit₹902 Cr₹751 Cr₹583 Cr₹689 Cr
EPS (₹)34.028.322.026.0
Quarterly history locked

Register free to see 9 more quarters.

Register free

Balance Sheet

Balance sheet
PeriodFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15
Liabilities
Equity Capital₹53 Cr₹53 Cr₹53 Cr
Reserves₹16,708 Cr₹14,916 Cr₹13,518 Cr
Borrowings₹7 Cr₹4 Cr₹3 Cr
Other Liabilities₹3,251 Cr₹1,948 Cr₹1,886 Cr
Total Liabilities₹20,019 Cr₹16,921 Cr₹15,460 Cr
Assets
Fixed Assets₹6,528 Cr₹5,442 Cr₹4,739 Cr
Investments₹69 Cr₹65 Cr₹82 Cr
Receivables———
Inventory———
Cash & Equivalents———
Other Assets₹11,309 Cr₹10,392 Cr₹9,861 Cr
Total Assets₹20,019 Cr₹16,921 Cr₹15,460 Cr
Balance sheet history locked

Register free to see 10 more years.

Register free

Cash Flow

Cash flow statement
PeriodOperatingInvestingFinancingNet Cash Flow
FY26₹2,738 Cr₹-2,219 Cr₹-804 Cr₹-285 Cr
FY25₹1,653 Cr₹-804 Cr₹-799 Cr₹50 Cr
FY24₹1,261 Cr₹-269 Cr₹-799 Cr₹193 Cr
FY23
FY22
FY21
FY20
FY19
FY18
FY17
FY16
FY15
Cash flow history locked

Register free to see 10 more years.

Register free

Peer Comparison

Peer comparison
CompanyM.CapP/EROE1Y Return
Sun Pharmaceutical Industries Ltd——+14.78%+7.18%
Dr Reddys Laboratories Ltd——+8.84%-3.74%
Cipla Ltd——+11.77%-5.50%
Apollo Hospitals Enterprise Ltd——+22.64%+23.01%
Max Healthcare Institute Ltd₹1,00,553 Cr67.2+14.7%+0.87%

Mutual Fund Holdings

Free account

Mutual fund holdings

Create a free account to see institutional ownership snapshots.

Register free

Bulk & Block Deals

Free account

Bulk & block deals

Create a free account to view recent institutional deal activity.

Register free

Analyst Estimates

Free account

Analyst estimates

Create a free account to view analyst estimate summaries.

Register free

Latest News

2026-08-10Shareholder Meeting / Postal Ballot-Outcome of AGMBSE Filing2026-08-04Divi's Laboratories Ltd (BOM:532488) (Q1 FY27) Earnings Call Highlights: Record Profit Surge ...GuruFocus.com

Documents & Filings

rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.